Anavex Life Sciences Corp. SEC filings AVXL
Anavex Life Sciences Corp. has 634 filings in SEC EDGAR's recent list, going back to Jan 13, 2005. Its latest annual report, Form 10-K, was filed on Nov 25, 2025 for the period ended Sep 30, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 28, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Nov 3, 2026 (officer or director change). The company's fiscal year ends on September 30.
| Form | Description | Filed | Period |
|---|---|---|---|
| 8-K |
Current report
Officer or director change
|
Nov 3, 2026 | Nov 1, 2026 |
| 8-K |
Current report
Officer or director change, Other events
|
Nov 2, 2026 | Oct 28, 2026 |
| 8-K |
Current report
Other events
|
Oct 20, 2026 | Oct 20, 2026 |
| 8-K |
Current report
Other events
|
Oct 15, 2026 | Oct 15, 2026 |
| 3 | Initial insider ownership | Oct 5, 2026 | Sep 24, 2026 |
| 3 | Initial insider ownership | Oct 5, 2026 | Sep 24, 2026 |
| 4 | Insider transaction | Sep 28, 2026 | Sep 24, 2026 |
| 8-K |
Current report
Change in control, Shareholder vote results
|
Sep 28, 2026 | Sep 24, 2026 |
| DFAN14A | Filing | Sep 21, 2026 | — |
| DFAN14A | Filing | Sep 18, 2026 | — |
| DFAN14A | Filing | Sep 17, 2026 | — |
| DEFA14A | Additional proxy material | Sep 15, 2026 | — |
| DFAN14A | Filing | Sep 15, 2026 | — |
| DEFA14A | Additional proxy material | Sep 14, 2026 | — |
| DFAN14A | Filing | Sep 10, 2026 | — |
| DFAN14A | Filing | Sep 10, 2026 | — |
| DFAN14A | Filing | Sep 9, 2026 | — |
| 8-K |
Current report
Other events
|
Sep 9, 2026 | Sep 9, 2026 |
| DEFA14A | Additional proxy material | Sep 8, 2026 | — |
| DEFA14A | Additional proxy material | Sep 4, 2026 | — |
| DFAN14A | Filing | Sep 4, 2026 | — |
| DFAN14A | Filing | Sep 3, 2026 | — |
| 8-K |
Current report
Other events
|
Sep 2, 2026 | Sep 2, 2026 |
| DFAN14A | Filing | Sep 2, 2026 | — |
| DEFA14A | Additional proxy material | Sep 1, 2026 | — |
| DEFA14A | Additional proxy material | Aug 31, 2026 | — |
| 10-Q | Quarterly report | Aug 28, 2026 | Jun 30, 2026 |
| 10-Q | Quarterly report | Aug 28, 2026 | Mar 31, 2026 |
| 10-Q/A | Amended quarterly report | Aug 28, 2026 | Dec 31, 2025 |
| 10-K/A | Amended annual report | Aug 28, 2026 | Sep 30, 2025 |
| DEFC14A | Filing | Aug 27, 2026 | — |
| PRRN14A | Filing | Aug 27, 2026 | — |
| 8-K |
Current report
Results of operations
|
Aug 25, 2026 | Aug 25, 2026 |
| DEFA14A | Additional proxy material | Aug 24, 2026 | — |
| DFAN14A | Filing | Aug 20, 2026 | — |
| PRRN14A | Filing | Aug 18, 2026 | — |
| DEFA14A | Additional proxy material | Aug 17, 2026 | — |
| DEFA14A | Additional proxy material | Aug 17, 2026 | — |
| 8-K |
Current report
Regulation FD disclosure
|
Aug 17, 2026 | Aug 17, 2026 |
| DEFA14A | Additional proxy material | Aug 11, 2026 | — |
| 8-K |
Current report
Regulation FD disclosure
|
Aug 11, 2026 | Aug 11, 2026 |
| DEFC14A | Form defc14a | Aug 11, 2026 | — |
| NT 10-Q | Form nt 10-q | Aug 10, 2026 | Jun 30, 2026 |
| 8-K |
Current report
Regulation FD disclosure
|
Aug 3, 2026 | Aug 3, 2026 |
| PREC14A | Form prec14a | Jul 31, 2026 | — |
| SCHEDULE 13G | Ownership over 5% (passive) | Jul 31, 2026 | — |
| 8-K |
Current report
Results of operations
|
Jul 30, 2026 | Jul 30, 2026 |
| PREC14A | Filing | Jul 24, 2026 | — |
| 8-K |
Current report
Other events
|
Jul 20, 2026 | Jul 20, 2026 |
| 8-K |
Current report
Other events
|
Jun 26, 2026 | Jun 25, 2026 |
| 8-K |
Current report
Listing notice, Other events
|
May 22, 2026 | May 20, 2026 |
| 8-K |
Current report
Officer or director change
|
May 15, 2026 | May 11, 2026 |
| 3 | Initial insider ownership | May 14, 2026 | May 4, 2026 |
| NT 10-Q | Form nt 10-q | May 11, 2026 | Mar 31, 2026 |
| 8-K |
Current report
Officer or director change
|
May 6, 2026 | Apr 30, 2026 |
| 3 | Initial insider ownership | May 1, 2026 | Feb 23, 2026 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Mar 26, 2026 | — |
| 8-K |
Current report
Other events
|
Mar 25, 2026 | Mar 25, 2026 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Feb 25, 2026 | Feb 20, 2026 |
| 10-Q | Quarterly report | Feb 9, 2026 | Dec 31, 2025 |
| 8-K |
Current report
Results of operations
|
Feb 9, 2026 | Feb 9, 2026 |
| 4 | Insider transaction | Jan 9, 2026 | Jan 6, 2026 |
| 4 | Insider transaction | Jan 9, 2026 | Jan 6, 2026 |
| 10-K | Annual report | Nov 25, 2025 | Sep 30, 2025 |
| 8-K |
Current report
Results of operations
|
Nov 25, 2025 | Nov 25, 2025 |
| 8-K |
Current report
Other events
|
Nov 14, 2025 | Nov 14, 2025 |
| 4 | Insider transaction | Oct 3, 2025 | Oct 2, 2025 |
| 4 | Insider transaction | Oct 3, 2025 | Oct 2, 2025 |
| 4 | Insider transaction | Sep 12, 2025 | Sep 11, 2025 |
| 4 | Insider transaction | Aug 22, 2025 | Aug 20, 2025 |
| 4 | Insider transaction | Aug 22, 2025 | Aug 20, 2025 |
| 10-Q | Quarterly report | Aug 12, 2025 | Jun 30, 2025 |
| 8-K |
Current report
Material agreement
|
Jul 28, 2025 | Jul 25, 2025 |
| 424B5 | Prospectus supplement | Jul 25, 2025 | — |
| EFFECT | Filing | Jul 23, 2025 | — |
| CORRESP | Letter to the SEC | Jul 21, 2025 | — |
| UPLOAD | Letter from the SEC | Jul 21, 2025 | — |
| S-3 | Shelf registration | Jul 14, 2025 | — |
| 8-K |
Current report
Officer or director change
|
Jul 3, 2025 | Jul 3, 2025 |
| 8-K |
Current report
Officer or director change, Shareholder vote results
|
Jun 13, 2025 | Jun 10, 2025 |
| 4 | Insider transaction | Jun 9, 2025 | Jun 5, 2025 |
| 10-Q | Quarterly report | May 13, 2025 | Mar 31, 2025 |
| 4 | Insider transaction | Apr 30, 2025 | Apr 28, 2025 |
| 4 | Insider transaction | Apr 30, 2025 | Apr 28, 2025 |
| ARS | Annual report to shareholders | Apr 25, 2025 | Sep 30, 2024 |
| DEFA14A | Additional proxy material | Apr 25, 2025 | — |
| DEF 14A | Proxy statement | Apr 25, 2025 | Apr 25, 2025 |
| 4 | Insider transaction | Apr 2, 2025 | Mar 31, 2025 |
| 4 | Insider transaction | Apr 2, 2025 | Mar 31, 2025 |
| 4 | Insider transaction | Apr 2, 2025 | Mar 31, 2025 |
| 4 | Insider transaction | Apr 2, 2025 | Mar 31, 2025 |
| 4 | Insider transaction | Apr 2, 2025 | Mar 31, 2025 |
| 4 | Insider transaction | Mar 26, 2025 | Mar 24, 2025 |
| 10-Q | Quarterly report | Feb 12, 2025 | Dec 31, 2024 |
| 4 | Insider transaction | Jan 17, 2025 | Jan 15, 2025 |
| 4 | Insider transaction | Jan 17, 2025 | Jan 15, 2025 |
| 4 | Insider transaction | Dec 23, 2024 | Dec 19, 2024 |
| 4 | Insider transaction | Dec 23, 2024 | Dec 19, 2024 |
| 10-K | Annual report | Dec 23, 2024 | Sep 30, 2024 |
| 4 | Insider transaction | Dec 6, 2024 | Nov 19, 2024 |
| 4 | Insider transaction | Dec 6, 2024 | Nov 19, 2024 |
| 10-Q | Quarterly report | Aug 6, 2024 | Jun 30, 2024 |
| 8-K |
Current report
Agreement ended
|
Jul 30, 2024 | Jul 24, 2024 |
| S-3 | Shelf registration | Jul 29, 2024 | — |
| 8-K |
Current report
Shareholder vote results
|
Jun 21, 2024 | Jun 18, 2024 |
| 4 | Insider transaction | Jun 17, 2024 | Jun 14, 2024 |
| 4 | Insider transaction | May 17, 2024 | May 15, 2024 |
| 10-Q | Quarterly report | May 9, 2024 | Mar 31, 2024 |
| 8-K |
Current report
Results of operations
|
May 9, 2024 | May 9, 2024 |
| DEFA14A | Additional proxy material | May 6, 2024 | — |
| DEF 14A | Proxy statement | May 6, 2024 | May 6, 2024 |
| 4 | Insider transaction | Apr 1, 2024 | Mar 28, 2024 |
| 144 | Notice of proposed sale | Mar 28, 2024 | — |
| 4 | Insider transaction | Feb 23, 2024 | Feb 20, 2024 |
| 4 | Insider transaction | Feb 23, 2024 | Feb 20, 2024 |
| 4 | Insider transaction | Feb 23, 2024 | Feb 20, 2024 |
| 4 | Insider transaction | Feb 23, 2024 | Feb 20, 2024 |
| 4 | Insider transaction | Feb 23, 2024 | Feb 20, 2024 |
| SC 13G/A | Amended ownership over 5% (passive) | Feb 13, 2024 | — |
| 10-Q | Quarterly report | Feb 7, 2024 | Dec 31, 2023 |
| SC 13G/A | Amended ownership over 5% (passive) | Jan 25, 2024 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Jan 22, 2024 | — |
| 4 | Insider transaction | Jan 12, 2024 | Jan 2, 2024 |
| 4 | Insider transaction | Jan 12, 2024 | Jan 2, 2024 |
| 10-K | Annual report | Nov 27, 2023 | Sep 30, 2023 |
| 10-Q | Quarterly report | Aug 8, 2023 | Jun 30, 2023 |
| 4 | Insider transaction | Jun 30, 2023 | Jun 28, 2023 |
| 144 | Notice of proposed sale | Jun 28, 2023 | — |
| 8-K |
Current report
Shareholder vote results
|
May 24, 2023 | May 23, 2023 |
| 10-Q | Quarterly report | May 9, 2023 | Mar 31, 2023 |
| 8-K |
Current report
Bylaw or fiscal year change
|
Apr 14, 2023 | Apr 11, 2023 |
| 4 | Insider transaction | Apr 4, 2023 | Mar 31, 2023 |
| 4 | Insider transaction | Apr 4, 2023 | Mar 31, 2023 |
| 4 | Insider transaction | Apr 4, 2023 | Mar 31, 2023 |
| 4 | Insider transaction | Apr 4, 2023 | Mar 31, 2023 |
| 4 | Insider transaction | Apr 4, 2023 | Mar 31, 2023 |
| DEFA14A | Additional proxy material | Apr 4, 2023 | — |
| DEF 14A | Proxy statement | Apr 4, 2023 | Apr 4, 2023 |
| 8-K |
Current report
Regulation FD disclosure
|
Mar 13, 2023 | Mar 10, 2023 |
| SC 13G/A | Amended ownership over 5% (passive) | Feb 9, 2023 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Feb 9, 2023 | — |
| 8-K |
Current report
Other events
|
Feb 7, 2023 | Feb 7, 2023 |
| 424B5 | Prospectus supplement | Feb 7, 2023 | — |
| 10-Q | Quarterly report | Feb 7, 2023 | Dec 31, 2022 |
| SC 13G/A | Amended ownership over 5% (passive) | Jan 31, 2023 | — |
| 10-K/A | Amended annual report | Jan 27, 2023 | Sep 30, 2022 |
| 8-K |
Current report
Other events
|
Dec 2, 2022 | Dec 1, 2022 |
| 10-K | Annual report | Nov 28, 2022 | Sep 30, 2022 |
| UPLOAD | Letter from the SEC | Aug 12, 2022 | — |
| CORRESP | Letter to the SEC | Aug 10, 2022 | — |
| 10-Q | Quarterly report | Aug 9, 2022 | Jun 30, 2022 |
| UPLOAD | Letter from the SEC | Jul 29, 2022 | — |
| 4 | Insider transaction | Jun 29, 2022 | Jun 27, 2022 |
| 4 | Insider transaction | Jun 29, 2022 | Jun 27, 2022 |
| 4 | Insider transaction | Jun 29, 2022 | Jun 27, 2022 |
| 4 | Insider transaction | Jun 29, 2022 | Jun 27, 2022 |
| 4 | Insider transaction | Jun 29, 2022 | Jun 27, 2022 |
| S-8 | Employee stock plan registration | Jun 10, 2022 | — |
| 4 | Insider transaction | May 27, 2022 | May 25, 2022 |
| 8-K |
Current report
Shareholder vote results
|
May 27, 2022 | May 24, 2022 |
| 10-Q | Quarterly report | May 10, 2022 | Mar 31, 2022 |
| DEFA14A | Additional proxy material | Apr 11, 2022 | — |
| DEF 14A | Proxy statement | Apr 11, 2022 | Apr 11, 2022 |
| 8-K |
Current report
Officer or director change
|
Apr 8, 2022 | Apr 7, 2022 |
| 8-K |
Current report
Auditor change, Officer or director change, Regulation FD disclosure
|
Mar 4, 2022 | Mar 4, 2022 |
| SC 13G | Ownership over 5% (passive) | Feb 9, 2022 | — |
| 10-Q | Quarterly report | Feb 9, 2022 | Dec 31, 2021 |
| SC 13G | Ownership over 5% (passive) | Feb 9, 2022 | — |
| 8-K |
Current report
Other events
|
Feb 4, 2022 | Feb 4, 2022 |
| SC 13G/A | Amended ownership over 5% (passive) | Feb 3, 2022 | — |
| 8-K |
Current report
Regulation FD disclosure
|
Feb 2, 2022 | Feb 2, 2022 |
| 10-K | Annual report | Nov 24, 2021 | Sep 30, 2021 |
| 8-K |
Current report
Other events
|
Sep 27, 2021 | Sep 27, 2021 |
| S-3ASR | Automatic shelf registration | Sep 24, 2021 | — |
| 8-K |
Current report
Regulation FD disclosure
|
Sep 13, 2021 | Sep 13, 2021 |
| 10-Q | Quarterly report | Aug 12, 2021 | Jun 30, 2021 |
| 4 | Insider transaction | Aug 4, 2021 | Aug 2, 2021 |
| 4 | Insider transaction | Aug 4, 2021 | Aug 2, 2021 |
| 4 | Insider transaction | Aug 4, 2021 | Aug 2, 2021 |
| 4 | Insider transaction | Aug 4, 2021 | Aug 2, 2021 |
| 4 | Insider transaction | Aug 4, 2021 | Aug 2, 2021 |
| 4 | Insider transaction | Aug 4, 2021 | Aug 2, 2021 |
| 4 | Insider transaction | Aug 4, 2021 | Aug 2, 2021 |
| 4 | Insider transaction | Jul 1, 2021 | Jun 29, 2021 |
| 4 | Insider transaction | Jul 1, 2021 | Jun 29, 2021 |
| 8-K |
Current report
Material agreement
|
Jun 24, 2021 | Jun 22, 2021 |
| 424B5 | Prospectus supplement | Jun 24, 2021 | — |
| 3 | Initial insider ownership | Jun 9, 2021 | May 25, 2021 |
| 8-K |
Current report
Bylaw or fiscal year change, Shareholder vote results
|
May 28, 2021 | May 25, 2021 |
| 4 | Insider transaction | May 25, 2021 | May 21, 2021 |
| 4 | Insider transaction | May 19, 2021 | May 17, 2021 |
| 10-Q | Quarterly report | May 13, 2021 | Mar 31, 2021 |
| DEF 14A | Proxy statement | Apr 12, 2021 | Apr 12, 2021 |
| S-8 | Employee stock plan registration | Apr 9, 2021 | — |
| PRE 14A | Preliminary proxy statement | Apr 1, 2021 | Apr 1, 2021 |
| 4 | Insider transaction | Feb 26, 2021 | Feb 24, 2021 |
| 4 | Insider transaction | Feb 23, 2021 | Feb 19, 2021 |
| 424B5 | Prospectus supplement | Feb 16, 2021 | — |
| 10-Q | Quarterly report | Feb 16, 2021 | Dec 31, 2020 |
| SC 13G/A | Amended ownership over 5% (passive) | Feb 16, 2021 | — |
Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Biological Products, (No Diagnostic Substances) (SIC 2836)
- Listed as
- AVXL (Nasdaq)
- Fiscal year ends
- September 30
- Headquarters
- New York, NY
- SEC filer status
- Large accelerated filer, Smaller reporting company
- SEC CIK
- 1314052
- Former names
- Thrifty Printing Inc. (until Jan 25, 2007)
Other Biological Products, (No Diagnostic Substances) companies
- Amgen Inc AMGN
- Gilead Sciences, Inc. GILD
- Moderna, Inc. MRNA
- Argenx SE ARGX
- Revolution Medicines, Inc. RVMD
- Biogen Inc. BIIB
- BioNTech SE BNTX
- Exelixis, Inc. EXEL
All 182 Biological Products, (No Diagnostic Substances) companies
Source: SEC EDGAR filings. This is company-reported data, not investment advice.